Ombretta Turriziani

Pubblicazioni

Titolo Pubblicato in Anno
Prevalence of SARS-CoV-2 infection and associated risk factors: A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021 FRONTIERS IN PUBLIC HEALTH 2022
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19 CLINICAL IMMUNOLOGY 2022
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation CLINICAL MICROBIOLOGY AND INFECTION 2022
Longitudinal virological and immunological profile in a case of human monkeypox infection OPEN FORUM INFECTIOUS DISEASES 2022
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations VACCINE. X 2022
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy SCIENTIFIC REPORTS 2022
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study INFECTION 2022
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) VIRUS RESEARCH 2021
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2021
The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study) JOURNAL OF MEDICAL VIROLOGY 2021
Molecular diagnosis of SARS-CoV-2 in seminal fluid JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2021
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients MICROORGANISMS 2021
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab THE LANCET MICROBE 2021
The synergistic effect of time of exposure, distance and no use of personal protective equipment in the determination of SARS-CoV-2 infection: Results of a contact tracing follow-up study in healthcareworkers INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α FORENSIC SCIENCE, MEDICINE AND PATHOLOGY 2021
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality NEW MICROBIOLOGICA 2021
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2 JOURNAL OF VIROLOGICAL METHODS 2021
CRISPR/Cas9 ablation of integrated HIV-1 accumulates proviral DNA circles with reformed LTRs JOURNAL OF VIROLOGY 2021
Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting AIDS RESEARCH AND HUMAN RETROVIRUSES 2021

ERC

  • LS6_5

Interessi di ricerca

L’infezione da SARS-CoV-2: diagnosi molecolare e gestione del paziente
Resistenza alla terapia antiretrovirale: effetti a lungo termine della terapia antiretrovirale sulla cellula e studio dei meccanismi di resistenza cellulare selezionati dopo trattamento. Ruolo dell’espressione di trasportatori di membrana nella resistenza ai farmaci antiretrovirali. Caratterizzazione in vitro di ceppi di HIV farmacoresistenti. Studio delle varianti di HIV-1 farmacoresistenti in soggetti HIV positivi e analisi del possibile ruolo delle varianti di HIV farmacoresistenti archiviate nei serbatoi cellulari, nel fallimento della terapia antivirale.
Significato clinico della viremia residua in HIV: studi volti ad identificare sia i fattori che contribuiscono alla presenza di viremia residua, sia la relazione esistente tra viremia residua e immunoattivazione/infiammazione cronica.
nel soggetto HIV positivo.
Latenza di HIV: Effetti della terapia antiretrovirale sui serbatoi cellulari del virus.
Diagnosi virologica: Studi volti alla validazione e “messa a punto” di test diagnostici. Analisi comparative di test diagnostici commerciali

Keywords

SARS- CoV-2
antiretroviral therapy hiv
HIV latency
drug resistance
antiretroviral therapy hiv

Gruppi di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma